Abstract
The study sought to explore if androgen receptor gene (AR) polymorphisms are associated with the risk of urothelial carcinoma (UC) which is male-predominant. AR CAG and GGN repeat lengths were analyzed in 277 UC cases and 280 age and sex-matched controls by direct sequencing of leukocyte DNA. Smoking habits were obtained using a structured questionnaire interview. Relative risks were compared between groups categorized by all possible cutoffs of AR CAG and GGN repeat lengths. Men and women who had 23 and 44 (cumulative) CAG repeats had a significantly greater risk of UC, respectively (OR 2.09, 95% CI: 1.05–4.17, p = 0.036 and OR 4.95, 95% CI: 1.56–15.73, p = 0.007). Amongst males who were medium-dose cigarette smokers, those who had 23 CAG and shorter GGN (<22) repeats, had an elevated risk than those with longer CAG and GGN (OR 4.32 and 4.57, p = 0.034 and 0.042, respectively). However, neither CAG nor GGN affected the UC risk in non-smokers or heavy smokers (≥25 packs per day-years). AR CAG polymorphism may affect the risk of UC in both genders. In addition, AR polymorphisms may influence carcinogenic effect of medium-dose of cigarette smoking in men.
Similar content being viewed by others
References
Hsing A.W., Gao Y.T., Wu G., Wang X., Deng J., Chen Y.L., Sesterhenn I.A., Mostofi F.K., Benichou J., Chang C. Polymorphic CAG and GGN repeat lengths in the androgen receptor gene and prostate cancer risk: a population-based case–control study in China. Cancer Res. 60: 5111–5116, 2000
Chamberlain N.L., Driver E.D., Miesfeld R.L., The length and location of CAG trinucleotide repeats in the androgen receptor N-terminal domain affect transactivation function. Nucleic Acids Res. 22: 3181–3186, 1994
Ding D., Xu L., Menon M., Reddy G.P., Barrack E.R., Effect of GGC (glycine) repeat length polymorphism in the human androgen receptor on androgen action. Prostate 62: 133, 2005
Montgomery J.S., Price D.K., Figg W.D., The androgen receptor gene and its influence on the development and progression of prostate cancer. J. Pathol. 195: 138–146, 2001
Yu H., Bharaj B., Vassilikos E.J., Giai M., Diamandis E.P., Shorter CAG repeat length in the androgen receptor gene is associated with more aggressive forms of breast cancer Breast Cancer Res. Treat. 59: 153–161, 2000
Li A.J., Baldwin R.L., Karlan B.Y., Short androgen receptor allele length is a poor prognostic factor in epithelial ovarian carcinoma. Clin. Cancer Res. 9: 3667–3673, 2003
Edwards S.M., Badzioch M.D., Minter R., Hamoudi R., Collins N., Ardern-Jones A., Dowe A., Osborne S., Kelly J., Shearer R., Easton D.F., Saunders G.F., Dearnaley D.P., Eeles R.A., Androgen receptor polymorphisms: association with prostate cancer risk, relapse and overall survival Int. J. Cancer 84: 458–465, 1999
Jemal A., Murray T., Samuels A., Ghafoor A., Ward E., Thun M.J., Cancer statistics, 2003 CA Cancer J. Clin. 53: 5–26, 2003
Boorman G.A., Animal model of human disease: carcinoma of the ureter and urinary bladder Am. J. Pathol. 88: 251–254, 1977
Cheng L., MacLennan G.T., Pan C.X., Jones T.D., Moore C.R., Zhang S., Gu J., Patel N.B., Kao C., Gardner T.A., Allelic loss of the active X chromosome during bladder carcinogenesis. Arch. Pathol. Lab. Med. 128: 187–190, 2004
Boorjian S., Ugras S., Mongan N.P., Gudas L.J., You X., Tickoo S.K., Scherr D.S., Androgen receptor expression is inversely correlated with pathologic tumor stage in bladder cancer. Urology 64: 383–388, 2004
Yeh S.H., Chang C.F., Shau W.Y., Chen Y.W., Hsu H.C., Lee P.H., Chen D.S., Chen P.J., Dominance of functional androgen receptor allele with longer CAG repeat in hepatitis B virus-related female hepatocarcinogenesis. Cancer Res. 62: 4346–4351, 2002
Burch J.D., Rohan T.E., Howe G.R., Risch H.A., Hill G.B., Steele R., Miller A.B., Risk of bladder cancer by source and type of tobacco exposure: a case–control study. Int. J. Cancer 44: 622–628, 1989
Chiou H.Y., Hsueh Y.M., Liaw K.F., Horng S.F., Chiang M.H., Pu Y.S., Lin J.S., Huang C.H., Chen C.J., Incidence of internal cancers and ingested inorganic arsenic: a seven-year follow-up study in Taiwan. Cancer Res. 55: 1296–1300, 1995
Suter N.M., Malone K.E., Daling J.R., Doody D.R., Ostrander E.A., Androgen receptor (CAG)n and (GGC)n polymorphisms and breast cancer risk in a population-based case–control study of young women. Cancer Epidemiol. Biomarkers Prev. 12: 127–135, 2003
Liede A., Zhang W., Leon Matsuda M.L., Tan A., Narod S.A., Androgen receptor gene polymorphism and breast cancer susceptibility in The Philippines. Cancer Epidemiol. Biomarkers Prev. 12: 848–852, 2003
Roberts R.O., Bergstralh E.J., Cunningham J.M., Hebbring S.J., Thibodeau S.N., Lieber M.M., Jacobsen S.J., Androgen receptor gene polymorphisms and increased risk of urologic measures of benign prostatic hyperplasia. Am. J. Epidemiol. 159: 269–276, 2004
Gacy A.M., Goellner G., Juranic N., Macura S., McMurray C.T., Trinucleotide repeats that expand in human disease form hairpin structures in vitro. Cell 81: 533–540, 1995
Yeap B.B., Wilce J.A., Leedman P.J., The androgen receptor mRNA. Bioessays 26: 672–682, 2004
Gottlieb B., Beitel L.K., Wu J.H., Trifiro M., The androgen receptor gene mutations database (ARDB): 2004 update. Hum. Mutat. 23: 527–533 2004
Choudhry M.A., McEwan I.J., In vitro regulation of reporter gene transcription by the androgen receptor AF1 domain. Biochem. Soc. Trans. 32:1103–1106 2004
Reid J., Betney R., Watt K., McEwan I.J., The androgen receptor transactivation domain: the interplay between protein conformation and protein–protein interactions. Biochem. Soc. Trans. 31: 1042–1046 2003
Heinlein C.A., Chang C., Androgen receptor (AR) coregulators: an overview. Endocr. Rev. 23: 175–200 2002
Yu M.C., Skipper P.L., Tannenbaum S.R., Chan K.K., Ross R.K., Arylamine exposures and bladder cancer risk. Mutat. Res. 506–507: 21–28 2002
Garcia-Closas M., Malats N., Silverman D., Dosemeci M., Kogevinas M., Hein D.W., Tardon A., Serra C., Carrato A., Garcia-Closas R., Lloreta J., Castano-Vinyals G., Yeager M., Welch R., Chanock S., Chatterjee N., Wacholder S., Samanic C., Tora M., Fernandez F., Real F.X., Rothman N., NAT2 slow acetylation, GSTM1 null genotype, and risk of bladder cancer: results from the Spanish Bladder Cancer Study and meta-analyses. Lancet 366: 649–659 2005
Matullo G., Guarrera S., Sacerdote C., Polidoro S., Davico L., Gamberini S., Karagas M., Casetta G., Rolle L., Piazza A., Vineis P., Polymorphisms/haplotypes in DNA repair genes and smoking: a bladder cancer case–control study. Cancer Epidemiol. Biomarkers Prev. 14: 2569–2578 2005
Berman D.M., Wang Y., Liu Z., Dong Q., Burke L.A., Liotta L.A., Fisher R., Wu X., A functional polymorphism in RGS6 modulates the risk of bladder cancer. Cancer Res. 64: 6820–6826 2004
Hsieh F.I., Pu Y.S., Chern H.D., Hsu L.I., Chiou H.Y., Chen C.J., Genetic polymorphisms of N-acetyltransferase 1 and 2 and risk of cigarette smoking-related bladder cancer. Br. J. Cancer 81: 537–541 1999
Yu M.W., Cheng S.W., Lin M.W., Yang S.Y., Liaw Y.F., Chang H.C., Hsiao T.J., Lin S.M., Lee S.D., Chen P.J., Liu C.J., Chen C.J., Androgen-receptor gene CAG repeats, plasma testosterone levels, and risk of hepatitis B-related hepatocellular carcinoma. J. Natl. Cancer Inst. 92: 2023–2028 2000
Visvanathan K., Helzlsouer K.J., Boorman D.W., Strickland P.T., Hoffman S.C., Comstock G.W., O’Brien T.G., Guo Y., Association among an ornithine decarboxylase polymorphism, androgen receptor gene (CAG) repeat length and prostate cancer risk. J. Urol. 171: 652–655 2004
Nakanishi H., Takeuchi S., Kato K., Shimizu S., Kobayashi K., Tatematsu M., Shirai T., Establishment and characterization of three androgen-independent, metastatic carcinoma cell lines from 3,2′-dimethyl-4-aminobiphenyl-induced prostatic tumors in F344 rats. Jpn. J. Cancer Res. 87: 1218–1226 1996
Svartberg J., Midtby M., Bonaa K.H., Sundsfjord J., Joakimsen R.M., Jorde R., The associations of age, lifestyle factors and chronic disease with testosterone in men: the Tromso Study. Eur. J. Endocrinol. 149: 145–152 2003
Trummer H., Habermann H., Haas J., Pummer K., The impact of cigarette smoking on human semen parameters and hormones. Hum. Reprod. 17: 1554–1559 2002
Marsh J.D., Lehmann M.H., Ritchie R.H., Gwathmey J.K., Green G.E., Schiebinger R.J., Androgen receptors mediate hypertrophy in cardiac myocytes. Circulation 98: 256–261 1998
Racchi O., Mangerini R., Rapezzi D., Rolfo M., Gaetani G.F., Ferraris A.M., X chromosome inactivation patterns in normal females. Blood Cells Mol. Dis. 24: 439–447 1998
Acknowledgements
This study was supported by grants (91GMP012-3 and 91GMP012-4) from the National Science Council, Executive Yuan, Republic of China.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Liu, CH., Huang, Jd., Huang, SW. et al. Androgen receptor gene polymorphism may affect the risk of urothelial carcinoma. J Biomed Sci 15, 261–269 (2008). https://doi.org/10.1007/s11373-007-9215-x
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11373-007-9215-x